UC Davis Medical Center has become the first hospital in Northern California to treat patients with moderate to severe ...
A new study finds that sleep timing is linked to dementia risk, as people with weak circadian rhythms face a 2.5 times higher ...
The recent update to Viatris centers on a refreshed US$16 price target, set against a fair value estimate that has inched from about US$12.44 to roughly US$12.67 as the affordable medicines theme ...
Viatris Inc. (NASDAQ:VTRS) also reported that the Japan Pharmaceuticals and Medical Devices Agency (PMDA) accepted its ...
Industry Trends and Global Forecasts, Till 2035" report has been added to ResearchAndMarkets.com's offering.The global GLP-1 market is estimated to grow from USD 62.2 billion in the current year to ...
Everyday Health on MSN
Can Wearable Devices Help Prevent Heart Disease?
Smartwatches and wearable heart monitors can help detect issues such as irregular heart rhythms. But they also have limits and do not replace a diagnosis.
The GLP-1 market is primed for substantial growth due to rising obesity and diabetes rates. Opportunities lie in expanding ...
Earlier this week, Viatris announced four pipeline milestones, including US FDA approval of its generic version of Sandostatin LAR Depot and regulatory progress on a low-dose contraceptive patch, an ...
Healthcare in 2025 saw rapid innovation, rising costs, ACA subsidy expiration, AI adoption, consolidation, and affordability ...
New technology is coming out that could let you check glucose levels without any needles. One of the most talked-about is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback